98%
921
2 minutes
20
Gastric cancer is a leading cause of cancer-related deaths worldwide, underscoring the need for early detection to improve patient survival rates. The current clinical gold standard for detection is histopathological image analysis, but this process is manual, laborious, and time-consuming. As a result, there has been growing interest in developing computer-aided diagnosis to assist pathologists. Deep learning has shown promise in this regard, but each model can only extract a limited number of image features for classification. To overcome this limitation and improve classification performance, this study proposes ensemble models that combine the decisions of several deep learning models. To evaluate the effectiveness of the proposed models, we tested their performance on the publicly available gastric cancer dataset, Gastric Histopathology Sub-size Image Database. Our experimental results showed that the top 5 ensemble model achieved state-of-the-art detection accuracy in all sub-databases, with the highest detection accuracy of 99.20% in the 160 × 160 pixels sub-database. These results demonstrated that ensemble models could extract important features from smaller patch sizes and achieve promising performance. Overall, our proposed work could assist pathologists in detecting gastric cancer through histopathological image analysis and contribute to early gastric cancer detection to improve patient survival rates.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217020 | PMC |
http://dx.doi.org/10.3390/diagnostics13101793 | DOI Listing |
Front Genet
August 2025
Department of Gastrointestinal and Hernia Surgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, China.
Background: Gastric cancer (GC) is a leading cause of cancer-related mortality; however, biomarkers predicting its immunotherapy resistance remain scarce. Vascular cell adhesion molecule ()-, an immune cell adhesion mediator, is implicated in tumor progression; however, its prognostic and immunomodulatory roles in GC remain unclear.
Methods: In this study, we analyzed expression and its clinical relevance in GC using RNA-sequencing data from The Cancer Genome Atlas.
Surg Case Rep
September 2025
Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Toyama, Japan.
Introduction: There are no reports of patients undergoing McKeown esophagectomy for esophageal cancer after undergoing pancreaticoduodenectomy for pancreatic cancer. We report the case of a patient who underwent subtotal esophagectomy and colon reconstruction after pancreaticoduodenectomy using the mesenteric approach.
Case Presentation: A 71-year-old male was diagnosed with advanced esophageal cancer.
Cancer Biol Med
September 2025
Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.
Cancer Med
September 2025
Division of Clinical & Translational Cancer Research, Medical Sciences Campus, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Background: Gastric cancer (GC) is the fourth leading cause of cancer-related death globally. Tumor profiling has revealed actionable gene alterations that guide treatment strategies and enhance survival. Among Hispanics living in Puerto Rico (PRH), GC ranks among the top 10 causes of cancer-related death.
View Article and Find Full Text PDFDiagn Pathol
September 2025
Department of Gastrointestinal Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Background: Gastric cancer is one of the most common cancers worldwide, with its prognosis influenced by factors such as tumor clinical stage, histological type, and the patient's overall health. Recent studies highlight the critical role of lymphatic endothelial cells (LECs) in the tumor microenvironment. Perturbations in LEC function in gastric cancer, marked by aberrant activation or damage, disrupt lymphatic fluid dynamics and impede immune cell infiltration, thereby modulating tumor progression and patient prognosis.
View Article and Find Full Text PDF